BioNTech SE

NASDAQ BNTX

Data sourced from iex and EODHD
Download Data

BioNTech SE Income Statement 2018 - 2024

This table shows the Income Statement for BioNTech SE going from 2018 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30
Revenue
M 2,730 3,819 6,618 9,184 12,213 17,311 18,565 21,191 23,303 18,977 13,790 7,770 2,503 482 165 126 110 109 144 136 110 84 20
Cost of Revenue
M 1,434 1,805 2,319 2,754 3,382 4,532 4,693 5,071 4,991 3,645 3,088 1,851 866 704 476 296 254 244 230 211 152 92 36
Gross Profit
M 1,295 2,014 4,299 6,430 8,831 12,779 13,871 16,120 18,312 15,332 10,702 5,919 1,637 -222 -311 -170 -144 -135 -86 -75 -42 -8 -15
Operating Expenses
M 1,767 1,324 842 659 287 136 -178 -265 -63 48 -126 1 -2 -140 68 60 53 46 45 41 26 16 6
Selling, General, and Administrative Expenses (SG&A)
M 508 510 501 506 514 485 490 416 332 280 181 138 108 84 61 49 45 38 40 36 23 14 7
Research and Development (R&D) Expenses
M 1,970 1,793 1,332 116 116 116 575 835 1,037 1,253 937 904 798 647 453 276 234 226 213 195 142 85 33
Other Operating Expenses
M -711 -980 -991 53 53 53 -725 -1,160 -1,382 -1,484 -1,244 -1,041 -909 -871 -447 -265 -226 -218 -207 -190 -139 -83 -33
Costs and Expenses
M 252 -637 -1,561 -2,004 -2,716 -3,885 -4,233 -4,698 -4,669 -3,228 -2,967 -1,768 -821 -837 -408 -236 -202 -198 -185 -171 -126 -75 -29
Operating Income
M -471 690 3,457 5,772 8,544 12,643 14,050 16,386 18,374 15,284 10,828 5,918 1,639 -82 -380 -230 -197 -182 -131 -116 -68 -24 -22
Interest Expense
M 27 124 264 266 271 173 18 14 9 5 26 47 56 56 32 11 4 4 4 5 3 2 2
Non-operating Income/Expense
M 330 208 139 141 99 311 591 644 398 156 -41 -172 -46 -63 -30 -2 5 2 14 7 9 6 0
EBT
M 147 1,186 3,696 5,912 8,644 12,954 14,495 16,719 18,422 15,046 10,538 5,663 1,550 -146 -410 -232 -192 -179 -122 -115 -65 -24 -23
Income Tax Provision
M 34 256 944 1,537 2,406 3,520 4,174 4,971 5,559 4,754 3,045 1,591 353 -161 0 -2 0 0 0 1 1 1 1
Income after Tax
M 113 930 2,751 4,375 6,238 9,434 10,322 11,748 12,863 10,293 7,493 4,072 1,197 15 -410 -230 -192 -179 -122 -116 -66 -25 -23
Non-Controlling Interest
M -351 -9 2,109 0 0 0 0 0 0 0 0 0 0 0 0 0 -20 -20 9 9 29 29 -
Net Income
M 321 482 642 1,785 3,457 7,156 10,322 11,748 12,863 10,293 7,493 4,072 1,197 15 -410 -230 -172 -159 -149 -119 -89 -48 -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 240,470,477.25 241,580,791.75 242,942,418.75 246,946,128.50 251,499,165.50 255,192,060.75 258,597,082.25 259,667,999.25 259,560,033.50 258,865,832.50 256,065,832.50 251,262,226.25 244,656,095.75 236,038,499.00 226,788,499.00 223,957,689.25 223,231,168.00 224,320,972.00 228,160,776.00 227,509,996.00 226,859,216.00 226,859,216.00 226,859,216.00
EBITDA
M 55 1,185 4,038 6,085 8,421 12,301 13,524 15,840 18,059 14,971 10,581 5,825 1,578 -99 -342 -186 -153 -142 -86 -81 -42 -9 -16
Depreciation and Amortization
M 190 338 327 161 -124 -342 -384 -239 30 75 62 51 43 39 36 36 35 34 32 29 20 13 5
EBIT
M -135 847 3,711 5,924 8,544 12,643 13,908 16,079 18,029 14,896 10,519 5,775 1,534 -138 -378 -221 -188 -176 -118 -110 -63 -22 -21
Income from Discontinued Operations
M - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 -
Tax Rate (Effective)
% 29.79 35.79 35.10 34.50 28.02 27.34 28.50 29.56 30.26 31.52 3.70 -4.40 -11.47 -19.31 0.43 0.73 0.11 0.11 -0.31 -0.93 -1.23 -1.83 -2.50
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Gross Profit Margin
% -9.27 -9.82 -10.84 -0.32 70.52 72.74 72.93 74.79 78.79 82.14 64.43 -16.44 -71.71 -132.99 -173.83 -134.56 -131.28 -124.93 -84.58 -80.53 -64.58 -31.31 -74.38
Operating Income Margin
% -140.63 -60.23 -49.88 -34.68 66.58 72.41 74.40 76.56 79.05 80.69 77.13 -11.34 -79.57 -153.43 -218.39 -181.48 -179.43 -167.76 -121.41 -115.76 -92.47 -54.90 -106.04
Net Income Margin
% 56.85 42.09 32.51 51.57 51.94 53.97 54.78 55.08 55.13 54.39 66.64 -24.39 -90.37 -152.39 -230.95 -179.37 -155.70 -146.30 -113.12 -115.82 -115.35 -75.29 -
EBITDA Ratio
% -80.39 -25.44 -14.38 -4.07 67.74 69.80 70.87 73.34 77.70 79.11 72.45 -11.99 -74.72 -134.65 -192.03 -144.79 -139.57 -131.18 -85.04 -86.62 -65.04 -34.33 -79.93
EBIT Ratio
% -92.73 -36.33 -24.33 -11.96 66.58 72.41 73.76 75.24 77.55 78.67 71.23 -16.39 -84.31 -151.85 -217.09 -173.99 -171.66 -162.37 -110.69 -110.98 -86.64 -53.00 -104.37
EBT Ratio
% -88.11 -30.03 -22.71 -11.40 68.19 74.01 76.77 78.29 79.09 79.46 73.04 -23.05 -96.17 -164.45 -231.60 -180.94 -175.31 -166.03 -114.32 -116.15 -90.14 -57.29 -112.30

StockViz Staff

September 19, 2024

Any question? Send us an email